AUPH - Aurinia Pharmaceuticals gains on speculation of Otsuka bid
- Aurinia Pharmaceuticals ( NASDAQ: AUPH ) rose 8% on speculation the company may be a target for Otsuka ( OTCPK:OTSKF ).
- Aurinia ( AUPH ) could be a potential takeover target for Otuska, according to a Betaville item earlier.
- Recall late May, Aurinia Pharmaceuticals touted long-term benefit of Lupkynis for lupus.
For further details see:
Aurinia Pharmaceuticals gains on speculation of Otsuka bid